Agenda - Thursday 15 November 2018

Please select the stream you wish to view

08:45 - 09:30

Registration

09:30 - 10:00

Keynote – Excellence across the care pathway: NICE and diabetes

NICE has produced over 40 pieces of guidance, advice and quality standards on every conceivable element of diabetes prevention, treatment and management. Find out how NICE’s recommendations are developed, and how they could help you to commission and provide high quality, person-centred care.

Dr Paul Chrisp
Director, Centre for Guidelines, NICE
10:05 - 10:35

ADA/EASD guidelines: Where do the SIGNs send us? Are the messages NICE?

Following the publication of the ADA/EASD guidelines for the Management of Hyperglycaemia in Type 2 Diabetes at EASD in 2018, Dr Seidu explores how these guidelines should impact the management of diabetes in the UK? Do the guidelines support the recommendations from SIGN and what update is needed from NICE? Learning outcomes: A chance to…


Head of Research, Primary Care Diabetes Europe and primary care research fellow in diabetes at the University of Leicester, Hockley Farm Medical Practice, University of Leicester, Leicester Diabetes Centre
This session has been organised by Napp Pharma
10:40 - 11:10

Individualising diabetes care for older people with a focus on frailty

Care for older people with diabetes has unique challenges.  Multiple comorbidities associated with ageing combined with the increased prevalence of geriatric syndromes and frailty contributes to the complexity of managing diabetes in older people.  Comprehensive geriatric assessment should be performed on the initial diagnosis of diabetes and annually thereafter.  Owing to the heterogeneous nature of…


Director, Foundation for Diabetes Research in Older People (FDROP), Diabetes Frail Ltd
11:10 - 12:00

NETWORKING & EXHIBITION

12:05 - 12:35

Biosimilars explained – what is a biosimilar and should I prescribe them in practice?

Learning objectives: What is a biologic and a biosimilar? Consider the complexity of biologics and how biosimilars are different from generic medicines. How is a biosimilar different from the reference biologic, and how this compares with batch-to-batch variations within the reference medicine How are biosimilars developed? Consider the different stages including the comparative quality, non-clinical…


GP Partner & Medical Education & Scottish Lead, North Berwick Health Centre, GPwSI Diabetes, Primary Care Diabetes Society
This session is organised and remunerated by Mylan
12:40 - 13:10

Tips for safer acute care for patients with diabetes

Summary: An increasing number of people with diabetes are presenting to hospital acutely unwell It is highly likely that the first healthcare professional who assesses and initially manages the patient will not be specialist in diabetes Opportunities to ensure safe, effective diabetes care from early in the hospital admission process are not fully appreciated or…


Consultant in Diabetes & Senior Clinical Lecturer, University Hospital Southampton NHS Trust & University of Southampton
13:10 - 14:25

NETWORKING & EXHIBITION

14:30 - 15:30

The Live Debate – Preventing childhood obesity – whose responsibility? Policymakers, professionals, family environments or technology?

The DPC2018 Live Debate will be packed full of explosive and contentious viewpoints about preventing childhood obesity.Our expert panel of leading healthcare experts and policy makers will present their views from four different angles.

Rt Hon Keith Vaz MP
Chair, APPG Diabetes
Dr Fiona Campbell
Consultant Diabetes Paediatrician, Leeds Children’s Hospital
Consultant in Diabetes & Senior Clinical Lecturer, University Hospital Southampton NHS Trust & University of Southampton
Health Promotion Officer, Royal College of Paediatrics and Child Health
15:30 - 15:55

NETWORKING & EXHIBITION

15:55 - 16:25

Improving outcomes in type 2 diabetes; a role for GLP-1 RA?

Despite recent advances in glucose-lowering therapies, rates of cardiovascular disease and mortality in people with type 2 diabetes, about 90% of whom have obesity or overweight, still remain high. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have proven good efficacy in glycaemic control and weight loss in patients with T2D. Furthermore, recent cardiovascular outcome trials suggest that…


Head of Research, Primary Care Diabetes Europe and primary care research fellow in diabetes at the University of Leicester, Hockley Farm Medical Practice, University of Leicester, Leicester Diabetes Centre
This session has been organised and funded by Novo Nordisk
08:45 - 09:30

Registration

09:30 - 10:00

Keynote – Excellence across the care pathway: NICE and diabetes

NICE has produced over 40 pieces of guidance, advice and quality standards on every conceivable element of diabetes prevention, treatment and management. Find out how NICE’s recommendations are developed, and how they could help you to commission and provide high quality, person-centred care.

Dr Paul Chrisp
Director, Centre for Guidelines, NICE
10:05 - 10:35

Vulnerable youth and children – diabetes management and support


Diabetes Youth Worker Manager, Leeds Teaching Hospitals NHS Trust
10:40 - 11:10

Improving outcomes for children with diabetes, lessons from the National Paediatric Diabetes Audit

The National Paediatric Diabetes Audit (NPDA) has collected data about process and outcomes for children and young people with diabetes living in England and Wales since 2003. No one would disagree that this is an essential component of driving quality improvement and leads to a better understanding of how delivery of care can be optimised.…


Paediatric Endocrinologist & Honorary Senior Lecturer University Hospital of Wales, Cardiff University
11:10 - 12:00

NETWORKING & EXHIBITION

12:05 - 13:10

Transition tightrope – supporting confident step change

This session looks at the best and not so optimal of the current systems used whilst transitioning care of a young person with diabetes from paediatric to adult services.  With speakers including consultants from paediatric and adult services, views from young people who’ve transitioned and families preparing their young person for transition, this session will…


Consultant diabetologist and Clinical lead for Young Adult and Transition diabetes Service, Royal Liverpool and Broadgreen University Hospitals NHS Trust
Dr Fiona Campbell
Consultant Diabetes Paediatrician, Leeds Children’s Hospital
Lynsey Choules
Person with Diabetes
Ellie Huckle
Person with Diabetes
13:10 - 14:25

NETWORKING & EXHIBITION

14:30 - 15:30

The Live Debate – Preventing childhood obesity – whose responsibility? Policymakers, professionals, family environments or technology?

The DPC2018 Live Debate will be packed full of explosive and contentious viewpoints about preventing childhood obesity.Our expert panel of leading healthcare experts and policy makers will present their views from four different angles.

Rt Hon Keith Vaz MP
Chair, APPG Diabetes
Dr Fiona Campbell
Consultant Diabetes Paediatrician, Leeds Children’s Hospital
Consultant in Diabetes & Senior Clinical Lecturer, University Hospital Southampton NHS Trust & University of Southampton
Health Promotion Officer, Royal College of Paediatrics and Child Health
15:30 - 15:55

NETWORKING & EXHIBITION

15:55 - 16:25

Using social media and tech to engage and empower younger patients

It can sometimes be challenging to engage younger people with managing their diabetes.  There is widespread use of social media and technology in this group already in relation to other aspects of their lives. With that in mind. it is possible to utilise social media and technology to help support diabetes care. Learning outcomes: To…


Consultant in Diabetes & Senior Clinical Lecturer, University Hospital Southampton NHS Trust & University of Southampton
08:45 - 09:30

Registration

09:30 - 10:00

Keynote – Excellence across the care pathway: NICE and diabetes

NICE has produced over 40 pieces of guidance, advice and quality standards on every conceivable element of diabetes prevention, treatment and management. Find out how NICE’s recommendations are developed, and how they could help you to commission and provide high quality, person-centred care.

Dr Paul Chrisp
Director, Centre for Guidelines, NICE
10:05 - 10:35

Diabetic Retinopathy – a practical guide

Learning outcomes: Overview of the care pathway for people with diabetes and their eye health. What secondary care (who are not ophthalmologists) can do to better work alongside and support specialists in this area. What practical advice can be given. The way that diabetic retinopathy actually affects vision.


Consultant Ophthalmic Surgeon, Medical Retina and Cataract, Moorfields Eye Hospital NHS Foundation Trust, London
10:40 - 11:10

Should we care about the Pancreas exocrine function in Diabetes?

Learning outcomes: To understand the link between the exocrine and endocrine function. Type3C – am I misdiagnosing? What is Pancreatic exocrine insufficiency and how do I diagnose & treat?


Associate Professor of Internal Medicine, Endocrinology & Diabetology, General Hospital Luebbecke-Rahden
This session is organised and remunerated by Mylan
11:10 - 12:00

NETWORKING & EXHIBITION

12:05 - 12:35

Delaying and preventing diabetic retinopathy in primary care

Diabetic retinopathy is one of the most feared complications of diabetes as it can lead to blindness. I will discuss the natural history of diabetic retinopathy and the role of primary care in preventing and delaying progression of this microvascular complication. We will look at how retinal images are graded in screening and how the…


Senior Research Officer and Informatics Lead, Diabetes Research Unit, Cymru, Swansea University Medical School
12:40 - 13:10

Hot topics in diabetic kidney disease – a primary care perspective

The primary care management of diabetic kidney disease (DKD) is increasingly complex; I will distill the key take home messages from the NICE CKD guideline relevant to primary care and discuss the latest evidence guiding optimal glycemic targets in those with DKD. Finally, I will provide an overview of the pharmacological management of hyperglycaemia in…


GPwSI Diabetes, Woodlands Medical Centre, Cardiff
13:10 - 14:25

NETWORKING & EXHIBITION

14:30 - 15:30

The Live Debate – Preventing childhood obesity – whose responsibility? Policymakers, professionals, family environments or technology?

The DPC2018 Live Debate will be packed full of explosive and contentious viewpoints about preventing childhood obesity.Our expert panel of leading healthcare experts and policy makers will present their views from four different angles.

Rt Hon Keith Vaz MP
Chair, APPG Diabetes
Dr Fiona Campbell
Consultant Diabetes Paediatrician, Leeds Children’s Hospital
Consultant in Diabetes & Senior Clinical Lecturer, University Hospital Southampton NHS Trust & University of Southampton
Health Promotion Officer, Royal College of Paediatrics and Child Health
15:30 - 15:55

NETWORKING & EXHIBITION

15:55 - 16:25

EMPA-REG OUTCOME: 3 years on, what are the implications for clinical practice?

Excess mortality in type 2 diabetes is largely related to an increased incidence of cardiovascular disease.1 Traditionally, the management of type 2 diabetes has focused on glycaemic control, but, with cardiovascular outcomes trials now providing evidence of a cardiovascular benefit with some glucose-lowering agents, is it time to re-think the way we manage type 2…


GP Partner & Medical Education & Scottish Lead, North Berwick Health Centre, GPwSI Diabetes, Primary Care Diabetes Society
Dr Yassir Javaid
GPwSI Cardiology & Cardiovascular Lead, Nene CCG
This promotional session is sponsored by the Boehringer Ingelheim and Lilly Diabetes Alliance. The funding provided for this session includes speaker honoraria and presentation development support. The presentation has been reviewed for medical accuracy and compliance with applicable laws and regulations.
08:45 - 09:30

Registration

09:30 - 10:00

Keynote – Excellence across the care pathway: NICE and diabetes

NICE has produced over 40 pieces of guidance, advice and quality standards on every conceivable element of diabetes prevention, treatment and management. Find out how NICE’s recommendations are developed, and how they could help you to commission and provide high quality, person-centred care.

Dr Paul Chrisp
Director, Centre for Guidelines, NICE
10:05 - 10:35

The Obesity Health Alliance – working together to influence obesity policy

This talk will discuss how health charities, medical royal colleges and campaign groups have been working together to influence Government on obesity prevention policies. Learning outcomes: An overview of the Government¹s current approach to reduce childhood obesity An understanding of the policies needed to reduce obesity A knowledge of how different organisations work together to…


Alliance Lead, Obesity Health Alliance (OHA)
10:40 - 11:10

A practical guide to low carbohydrate diabetes management – lessons from the Bermuda Triangle

The presentation will describe the benefits of carbohydrate restriction in type 2 diabetes, how it can help towards reversal of type 2 diabetes and practical tips on advising dietary change and adjusting medication. It will show how this approach leads to weight loss, lower HbA1c and less need for medication with examples from the diabetes…


Independent Consultant & Author
11:10 - 12:00

NETWORKING & EXHIBITION

12:05 - 12:35

Childhood obesity and T2 diabetes – spotting it early and tools for combatting

This presentation will highlight the methods used to identify weight gain and obesity in young people at risk of Type 2 diabetes and those already diagnosed. It will address the common challenges that are faced with achieving a healthy weight in this patient group and the approaches we are taking in Leeds to support and…


Paediatric Dietitian, Leeds Children’s Hospital
13:10 - 14:25

NETWORKING & EXHIBITION

14:30 - 15:30

The Live Debate – Preventing childhood obesity – whose responsibility? Policymakers, professionals, family environments or technology?

The DPC2018 Live Debate will be packed full of explosive and contentious viewpoints about preventing childhood obesity.Our expert panel of leading healthcare experts and policy makers will present their views from four different angles.

Rt Hon Keith Vaz MP
Chair, APPG Diabetes
Dr Fiona Campbell
Consultant Diabetes Paediatrician, Leeds Children’s Hospital
Consultant in Diabetes & Senior Clinical Lecturer, University Hospital Southampton NHS Trust & University of Southampton
Health Promotion Officer, Royal College of Paediatrics and Child Health
15:30 - 15:55

NETWORKING & EXHIBITION

15:55 - 16:25

Emotional Eating

We rarely eat to satisfy true physiological hunger. Consumption of certain foods are utilised to aid in emotional repression and therapy and these foods can override the hormonal controlled hunger centre – making them far easier to overconsume. Knowing how to identify triggers and how to identify psychological compared to physiological hunger are key considerations…


Matthew Whitaker
Researcher and Trainer in Public Health, Xpert Health
08:45 - 09:30

Registration

09:30 - 10:00

Keynote – Excellence across the care pathway: NICE and diabetes

NICE has produced over 40 pieces of guidance, advice and quality standards on every conceivable element of diabetes prevention, treatment and management. Find out how NICE’s recommendations are developed, and how they could help you to commission and provide high quality, person-centred care.

Dr Paul Chrisp
Director, Centre for Guidelines, NICE
10:05 - 10:35

Choosing the right one – the technology toolkit

Using technology as an adjunct to education to support self-management for better clinical and psychosocial outcomes; working out which technology would be best for the individual and aligning your and your patient’s expectations. Learning outcomes: A problem-solving approach to identifying the most suitable technology at a given point in time Some psychosocial & clinical dimensions…


INPUT Patient Advocacy
INPUT Patient Advocacy
10:40 - 11:10

Data, Devices, Doctors and Diabetes – why the NHS and and the device industry need to change approach

Few areas of medicine are advancing as fast as diabetes technology. Unfortunately, the NHS is ill equipped to manage wholesale implementation with appropriate data use. This talk will attempt to address the issues and use the LifeScan OneTouch Verio Flex meter and OneTouch Reveal Software to illustrate appropriate technology and im-proved data management Learning outcomes:…


Dr Kenneth Robertson
Consultant Paediatrician, Greater Glasgow & Clyde
11:10 - 12:00

NETWORKING & EXHIBITION

12:05 - 12:35

The magic of diabetes data: Insights that improve diabetes

Optimising diabetes treatment plans is all about information. The more you know about your patient, the better care you will be able to deliver. And now – technology has brought us to a point where data from many different sources can paint a whole new picture of how well someone is responding to their treatment.…


Consultant in Diabetes & Senior Clinical Lecturer, University Hospital Southampton NHS Trust & University of Southampton
12:40 - 13:10

Flash Glucose Monitoring – From Clinical Practice to Real World Practice

More and more people living with Type 1 diabetes in the UK have access to the FreeStyle Libre system. This raises important questions around the clinical data and real-life experiences of the flash glucose monitoring system. In this session Dr Ajjan will present clinical evidence demonstrating the benefit of the flash glucose monitoring system in…


Dr Ramzi Ajjan
Associate Professor & Consultant in Diabetes & Endocrinology, The Leeds Teaching Hospitals NHS Trust
13:10 - 14:25

NETWORKING & EXHIBITION

14:30 - 15:30

The Live Debate – Preventing childhood obesity – whose responsibility? Policymakers, professionals, family environments or technology?

The DPC2018 Live Debate will be packed full of explosive and contentious viewpoints about preventing childhood obesity.Our expert panel of leading healthcare experts and policy makers will present their views from four different angles.

Rt Hon Keith Vaz MP
Chair, APPG Diabetes
Dr Fiona Campbell
Consultant Diabetes Paediatrician, Leeds Children’s Hospital
Consultant in Diabetes & Senior Clinical Lecturer, University Hospital Southampton NHS Trust & University of Southampton
Health Promotion Officer, Royal College of Paediatrics and Child Health
15:30 - 15:55

NETWORKING & EXHIBITION

15:55 - 16:25

Immersive learning: virtual, augmented and mixed reality

The objective of immersive learning is to create an experience where natural behaviors surface repeatedly through multiple iterations, which are subsequently followed by reflective conversations that trigger realisations.  Virtual, augmented and mixed realities enable these environments which can be used to enable and sustain behaviour change. Learn how immersive learning is being used in the diabetes…


CEO, Diabetes.co.uk
08:45 - 09:30

Registration

09:30 - 10:00

Keynote – Excellence across the care pathway: NICE and diabetes

NICE has produced over 40 pieces of guidance, advice and quality standards on every conceivable element of diabetes prevention, treatment and management. Find out how NICE’s recommendations are developed, and how they could help you to commission and provide high quality, person-centred care.

Dr Paul Chrisp
Director, Centre for Guidelines, NICE
10:05 - 10:35

Safe driving and diabetes – DVLA guidelines

There are 5 fatalities annually and up to 45 serious events every month associated with diabetes and driving. European guidance (2012) on diabetes and driving was taken up by the DVLA. This resulted in recommendations, which included that two hypoglycaemia events (day or night) in one year where 3rd party assistance was required would result…


Nurse Consultant- Diabetes, University Hospitals of Leicester NHS Trust, Associate Professor, University of Leicester, Co-Chair TREND-UK
10:40 - 11:20

Good Injection technique and Lipohypertrophy Screening inc Palpatation

This presentation will start by looking at the causes and impact of Lipohypertrophy. The presentation will include a live demonstration of the correct procedure for detecting and palpating lipohypertrophic lesions, there will then be the opportunity to examine a person with diabetes who injects to detect and palpate actual lipohypertrophic lesions. Learning outcomes: Describe what…


Nurse Consultant – Diabetes, Barnet Enfield & Haringey MHT, Co-Chair TREND-UK and Chair, ITM
11:10 - 12:00

NETWORKING & EXHIBITION

12:05 - 12:35

Interpretation of BG data & profiles

Being presented with a record book with a wide range of blood glucose results can be daunting! Blood glucose monitoring should be a tool to facilitate a discussion about effective diabetes management between the person with diabetes and the healthcare professional supporting them. This session describes a simple process for identifying patterns in blood glucose…


Independent Diabetes Nurse Consultant, TREND-UK
12:40 - 13:10

Top Ten Tips for Using Insulin Safely and Effectively in Primary Care

The extent to which primary care clinicians are involved in insulin management varies and will be influenced by local arrangements for service delivery as well as an individual’s interest and competency in this aspect of diabetes care. It is, however, inevitable that most doctors, nurses and increasingly pharmacists will, at some point, be required to…


Jane Diggle
Practice Nurse with an interest in Diabetes, TREND UK
13:10 - 14:25

NETWORKING & EXHIBITION

14:30 - 15:15

Diabetes care at end of life

As end of life approaches, the focus in diabetes management moves from reducing the risk of developing long-term complications to symptom control, the easing of targets and avoidance of acute complications. This session uses examples of people with type 1 and those with type 2 diabetes, with expected life of a year left to just…


Independent Diabetes Nurse Consultant, TREND-UK
14:30 - 15:30

The Live Debate – Preventing childhood obesity – whose responsibility? Policymakers, professionals, family environments or technology?

The DPC2018 Live Debate will be packed full of explosive and contentious viewpoints about preventing childhood obesity.Our expert panel of leading healthcare experts and policy makers will present their views from four different angles.

Rt Hon Keith Vaz MP
Chair, APPG Diabetes
Dr Fiona Campbell
Consultant Diabetes Paediatrician, Leeds Children’s Hospital
Consultant in Diabetes & Senior Clinical Lecturer, University Hospital Southampton NHS Trust & University of Southampton
Health Promotion Officer, Royal College of Paediatrics and Child Health
Novo Nordisk Banner

Our site is intended for UK Healthcare Professionals

Are you a UK Healthcare Professional?

We’re sending you to our partner charity’s site. 

DRWF provide information and support for people with diabetes and their friends & families